Cargando…
In Silico Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa
Buruli ulcer (BU) is caused by Mycobacterium ulcerans and is predominant in both tropical and subtropical regions. The neglected debilitating disease is characterized by chronic necrotizing skin lesions attributed to a mycolactone, which is a macrolide toxin secreted by M. ulcerans. The preferred tr...
Autores principales: | Kwofie, Samuel K., Dankwa, Bismark, Odame, Emmanuel A., Agamah, Francis E., Doe, Lady P. A., Teye, Joshua, Agyapong, Odame, Miller, Whelton A., Mosi, Lydia, Wilson, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6100440/ https://www.ncbi.nlm.nih.gov/pubmed/29954088 http://dx.doi.org/10.3390/molecules23071550 |
Ejemplares similares
-
Molecular Docking and Dynamics Simulation Studies Predict Munc18b as a Target of Mycolactone: A Plausible Mechanism for Granule Exocytosis Impairment in Buruli Ulcer Pathogenesis
por: Kwofie, Samuel K., et al.
Publicado: (2019) -
Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions
por: Gyamfi, Elizabeth, et al.
Publicado: (2021) -
Molecular modelling and de novo fragment-based design of potential inhibitors of beta-tubulin gene of Necator americanus from natural products
por: Agyapong, Odame, et al.
Publicado: (2021) -
Rapid Extraction Method of Mycobacterium ulcerans DNA from Clinical Samples of Suspected Buruli Ulcer Patients
por: Frimpong, Michael, et al.
Publicado: (2019) -
Caregiver burden in Buruli ulcer disease: Evidence from Ghana
por: Amoako, Yaw Ampem, et al.
Publicado: (2021)